Israel Englander’s Kite Pharma, Inc. KITE Stock Holding History

Israel Englander’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-34,394	Closed	-$6.18M	–	4308
2017 Q3	$6.18M	Buy	+34,394	New	+$4.79M	0.01%	1543
2017 Q2	–	Sell	-16,140	Closed	-$1.27M	–	4136
2017 Q1	$1.27M	Buy	+16,140	New	+$998K	﹤0.01%	2260
2016 Q1	–	Sell	-14,686	Closed	-$711K	–	3897
2015 Q4	$905K	Sell	14,686 -11,314	-44%	-$796K	﹤0.01%	2352
2015 Q3	$1.45M	Buy	26,000 +6,682	+35%	+$420K	﹤0.01%	2099
2015 Q2	$1.18M	Buy	+19,318	New	+$1.1M	﹤0.01%	2200

Israel Englander's KITE Position: Q4 2017 in Review

Israel Englander sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 34,394 shares — an estimated $6.18M sold.

Israel Englander first reported a position in KITE in Q2 2015 and held it in 5 quarters. The position peaked at $6.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Israel Englander reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Israel Englander sold 34,394 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.18M.
Israel Englander first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 5 quarters.
Israel Englander's Kite Pharma, Inc. position peaked at $6.18M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.